Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Rabbit ATG"'
Autor:
Asahito Hama, Nozomu Kawashima, Motoharu Hamada, Nobuhiro Nishio, Seiji Kojima, Eri Nishikawa, Shinji Nakao, Yusuke Okuno, Daisuke Ichikawa, Hideki Muramatsu, Kyogo Suzuki, Hirohito Yamazaki, Yoshiyuki Takahashi, Atsushi Narita
Publikováno v:
European Journal of Haematology. 107:255-264
Objectives Patients with acquired aplastic anemia (AA) without HLA-matched sibling donors or aged >40 years receive immunosuppressive therapy (IST) with anti-thymocyte globulin (ATG). We investigated the relationship between plasma rabbit ATG (r-ATG)
Autor:
Lixian Chang, Li-Peng Liu, Ye Guo, Meihui Yi, Yuanyuan Ren, Aoli Zhang, Chao Liu, Jing Feng, Shu-Chun Wang, Yang Lan, Yuli Cai, Xiaofan Zhu, Jingliao Zhang, Xiao-Yan Chen
Publikováno v:
Annals of Hematology. 100:53-61
This study retrospectively analyzed the clinical outcome of 172 children with newly diagnosed severe aplastic anemia (SAA) between January 2008 and April 2018, who received rabbit antithymocyte globulin (ATG) and cyclosporine (CsA) as first-line trea
Autor:
G X Peng, Fengkui Zhang, L P Jing, Yuan Li, Song L, W R Yang, L Ye, Yangmin Zhu, Xin Zhao, Kang Zhou, H H Fan, Jianping Li, Yang Yang, Li Zhang, Yang Li
Publikováno v:
European Journal of Haematology. 104:562-570
Objective To assess the outcomes of children with acquired aplastic anemia (AA) treated in China with first-line porcine anti-lymphocyte immunoglobulin (p-ALG)/rabbit anti-thymocyte immunoglobulin (r-ATG) combined with cyclosporine A (CSA). Methods W
Autor:
Sylvie Chevret, Valérie Guérin, Mony Fahd, Jean-Hugues Dalle, Karima Yakouben, André Baruchel, Lou le Mouel, Camille Feltesse, Jérôme Le Goff, Marie Ouachee, Guislaine Carcelain
Publikováno v:
Blood. 136:24-25
Introduction Thymoglobulin® and Grafalon® are 2 polyclonal rabbit anti-thymocyte globulin (ATG) used in allogeneic hematopoietic stem cell transplantation (allo-HSCT) to prevent graft rejection and graft-versus-host disease (GvHD). Differences in m
Autor:
Hirohito Yamazaki, Shinji Nakao, Fang Liu, Seiji Kojima, Jong Wook Lee, Atsushi Narita, Wenyu Yang, Xiaojuan Chen, Hoon Kook, Kensuke Usuki, Jingliao Zhang, Yoshiyuki Takahashi, Jun H Jang, Xiaofan Zhu, Hawk Kim, Hideki Muramatsu, Ye Guo
Publikováno v:
British journal of haematologyReferences. 187(2)
The treatment of choice for patients with severe aplastic anaemia (SAA) includes immunosuppressive therapy (IST) with anti-thymocyte globulin (ATG) and ciclosporin A. However, the optimal dose for rabbit ATG has yet to be established. We herein repor
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sujith Samarasinghe, Neha Bhatnagar
Publikováno v:
Paediatrics and Child Health. 25:343-349
Aplastic anaemia is a rare disorder in children. ∼20% of cases are inherited, whilst the rest are considered as acquired or idiopathic where no cause can be found. Diagnosis of the inherited causes of aplastic anaemia can be challenging but it is i
Autor:
Long-Mei Qin, Zhaoyue Wang, Hongshi Shen, Pingping Sha, Qing-Ya Cui, Tianqin Wu, Haifei Chen, Zhengyang Li
Publikováno v:
International journal of hematology. 107(1)
Immunosuppressive therapy (IST) with antithymocyte globulin (ATG) and cyclosporine (CsA) is the standard treatment for children with severe aplastic anemia (SAA) with no human leukocyte antigen-matched siblings. Due to the unavailability of horse ATG
Autor:
Gregory I Snell, Charles W. Hoopes, Glen P. Westall, Bronwyn Levvey, Atul C. Mehta, Shaf Keshavjee, Peter Jaksch, Elbert P. Trulock, Vivek N. Ahya
Publikováno v:
American Journal of Transplantation. 14:1191-1198
ATG-Fresenius S (ATG-F) is a polyclonal anti-human-T-lymphocyte immunoglobulin preparation that has been clinically developed to prevent episodes of acute cellular rejection. This study evaluated the efficacy and safety of ATG-F at doses of 5 and 9 m
Autor:
Kaan Kavakli, Nihal Karadaş, Deniz Yilmaz Karapinar, Can Balkan, Yilmaz Ay, Yesim Aydinok, Mehmet Akin
Publikováno v:
Pediatric Hematology and Oncology. 31:20-28
Acquired severe aplastic anemia (SAA) is a life threatening bone marrow failure characterized by pancytopenia and hypocellular bone marrow. Matched sibling donor is not available for majority of the patients and many children receive immunosuppressiv